Relationship Between Asthma Therapy Types, Pulmonary Function, and Asthma Control in Primary Healthcare Facilities in Medan
Authors
Abstract
Introduction: Asthma is a chronic respiratory disease that affects millions globally. Effective asthma therapy is essential for improving pulmonary function and achieving asthma control. However, many patients remain uncontrolled despite treatment. This study aims to evaluate the relationship between asthma therapy types, pulmonary function, and asthma control in primary healthcare facilities in Medan.
Method: This retrospective descriptive study utilized medical records of asthma patients from May 2022 to May 2023 at several primary healthcare centers in Medan. Data collected included demographic characteristics, asthma therapy types (inhaler vs. inhaler + oral), pulmonary function (APE prediction), and asthma control levels. Chi-Square tests were performed to assess statistical associations.
Results: The study found that most asthma patients were female (83.3%) and over 50 years old (62.5%). Regarding pulmonary function, 73.0% of patients had an APE prediction of ≥60%, indicating relatively good lung function. However, asthma control remained poor, with 68.8% of patients classified as uncontrolled. The majority of patients (68.8%) used inhalers as their primary therapy, while 31.2% received a combination of inhaler and oral medication. Statistical analysis showed no significant relationship between the type of asthma therapy and pulmonary function (p = 1.000), nor between the type of therapy and asthma control level (p = 0.067).
Conclusion: The study found no significant relationship between asthma therapy type, pulmonary function, and asthma control level. These findings suggest that other factors, such as therapy adherence, proper inhaler technique, and medication adjustments, may contribute to asthma control.
Similar Articles
- Roni Abimanyu, Andika Sitepu, Ali Nafiah Nasution, Comparison of Syntax II Score And Grace Score As Predictors of Major Cardiovascular Events 30 Days after Treatment in STEMI Undergoing PPCI , Journal of Society Medicine: Vol. 3 No. 6 (2024): June
- Mohammed Habib, Rosuvastatin Plus N Acetylcysteine to Prevention of Contrast Induced Acute Kidney Injury in Patients with Low Mehran Risk Score , Journal of Society Medicine: Vol. 3 No. 6 (2024): June
- Romi Ridwan, Ezra Oktaliansyah, Case Series of Guillain Barre Syndrome with Plasmaparesis in The ICU Bandung Hospital , Journal of Society Medicine: Vol. 3 No. 4 (2024): April
- Al-Ma’ Arij Akbar Lubis, Cut Aryfa Andra, Andre Pasha Ketaren, Relationship between QTc interval prolongation and mortality of acute ischaemic stroke patients during treatment and three months after treatment at Adam Malik Hospital , Journal of Society Medicine: Vol. 3 No. 3 (2024): March
- Cindy Giovanni, Nurita Dian Kestriani Saragi Sitio, Role of Intravenous Immunoglobulin (IVIG) in Patients with Guillain Barre Syndrome with Severe Community Pneumonia in The Intensive Care Unit (ICU) , Journal of Society Medicine: Vol. 3 No. 3 (2024): March
- Nurvira Annisa Saragih, Alfansuri Kadri, Chairil Amin Batubara, Short-Term Prognostic Model for Non-Traumatic Intracerebral Hemorrhage Patients: A Combination of Four Score, FUNC Score, and ICH Score , Journal of Society Medicine: Vol. 3 No. 1 (2024): January
- Amirra Fairuz SMW, Tubagus Ferdi Fadilah, Maternal Knowledge of Exclusive Breastfeeding and Nutritional Status of Children Under Two Years During the COVID-19 Pandemic , Journal of Society Medicine: Vol. 4 No. 1 (2025): January
- Mufti Muhammad, Netty DL, Chairil AB, Relationship between Hypertension and Aorta Arch Calcification on Chest X-Ray Photos of Ischemic Stroke Patients at The General Hospital Haji Adam Malik Medan 2022 , Journal of Society Medicine: Vol. 2 No. 9 (2023): September
- Ira Mendrofa, Imam Budi Putra, The Role of Herbal Medicine for Hypertrophic Scars Management , Journal of Society Medicine: Vol. 4 No. 1 (2025): January
- Putri Wulandari Harahap, Setia Putra Tarigan, Noni Novisari Soeroso, Taufik Ashar, Effectiveness of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) on Life Expectancy in Non-Small Cell Lung Cancer Patients in Medan City , Journal of Society Medicine: Vol. 4 No. 2 (2025): February
You may also start an advanced similarity search for this article.